2 citations
,
November 1999 in “Hair transplant forum international” The document's conclusion cannot be provided because the document is not accessible.
28 citations
,
July 1993 in “The journal of investigative dermatology/Journal of investigative dermatology”
January 2017 in “International journal of science and research” Trichotillomania is a chronic hair-pulling disorder, more common in females, treated with therapy and sometimes medication.
9 citations
,
January 2012 in “International journal of trichology” Trichostasis spinulosa can be diagnosed with a simple skin biopsy and treated with specific gels, but lesions may return after stopping treatment.
46 citations
,
October 2018 in “JCI insight” CD8+ T cells are involved in alopecia areata and may cause disease relapse.
January 2019 in “프로그램북(구 초록집)” Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.
June 2025 in “International Journal of Science and Research (IJSR)” Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.
8 citations
,
May 2017 in “Singapore Medical Journal” A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.
8 citations
,
October 2012 in “Transgenic Research” Overexpressing the human H-ferritin gene in mice causes mild growth delay and temporary hair loss.
January 2020 in “Juntendo Medical Journal” The document's conclusion cannot be determined as the content is not available.
January 2024 in “Dermatologic Therapy” Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.
9 citations
,
January 2021 in “Mediators of Inflammation” 15d‐PGJ2 cream protects against UVB-induced skin damage in mice.
November 2023 in “Journal of Investigative Dermatology” JAK inhibitors are effective and generally safe for treating alopecia areata, but monitoring for side effects is important.
Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.
January 1999 in “Hair transplant forum international” The document could not be processed for a summary.
January 2025 in “Thieme Medical and Scientific Publishers Private Limited eBooks” February 2023 in “Reactions Weekly” 4 citations
,
July 2023 in “Nature Medicine” The FDA approved a new Pfizer drug for hair loss in teens.
June 2025 in “British Journal of Dermatology” Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.
January 2019 in “Deleted Journal” 147 citations
,
August 2005 in “The Plant Cell” The TIP1 gene is crucial for normal plant cell growth in Arabidopsis.
1 citations
,
September 1994 in “Hair transplant forum international” The document's content cannot be understood or processed.
October 2025 in “Open Repository of the University of Porto (University of Porto)”
January 2023 in “Editora Enterprising eBooks” The text discusses whether Brazil's Vice-Presidency is a strategic tool or just a ceremonial government position.
January 2023 in “Editora Enterprising eBooks” The document discusses various research topics relevant to Brazil's social and scientific development.
1 citations
,
September 2016 in “Journal of Dermatological Science” Claudin-1 is crucial for maintaining skin barrier and preventing inflammation.
March 2016 in “Hair transplant forum international” The document could not be processed for a summary.
September 1994 in “Hair transplant forum international” The document's conclusion cannot be provided because the content is not available to parse.
October 2022 in “Amplla Editora eBooks” The document's conclusion cannot be provided because the document is not accessible or understandable.